- Home
- LEXX vs GENK Comparison
LEXX vs GENK Comparison
Compare LEXX & GENK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEXX
- GENK
- Stock Information
- Founded
- LEXX 2004
- GENK 2011
- Country
- LEXX Canada
- GENK United States
- Employees
- LEXX N/A
- GENK N/A
- Industry
- LEXX Biotechnology: Pharmaceutical Preparations
- GENK Restaurants
- Sector
- LEXX Health Care
- GENK Consumer Discretionary
- Exchange
- LEXX Nasdaq
- GENK Nasdaq
- Market Cap
- LEXX 39.1M
- GENK 36.5M
- IPO Year
- LEXX N/A
- GENK 2023
- Fundamental
- Price
- LEXX $1.84
- GENK $6.96
- Analyst Decision
- LEXX Strong Buy
- GENK Strong Buy
- Analyst Count
- LEXX 2
- GENK 3
- Target Price
- LEXX $11.00
- GENK $13.17
- AVG Volume (30 Days)
- LEXX 245.8K
- GENK 54.5K
- Earning Date
- LEXX 01-10-2025
- GENK 03-05-2025
- Dividend Yield
- LEXX N/A
- GENK N/A
- EPS Growth
- LEXX N/A
- GENK 483.78
- EPS
- LEXX N/A
- GENK 0.17
- Revenue
- LEXX $496,923.00
- GENK $198,834,000.00
- Revenue This Year
- LEXX $20.39
- GENK $14.66
- Revenue Next Year
- LEXX $113.25
- GENK $21.47
- P/E Ratio
- LEXX N/A
- GENK $41.10
- Revenue Growth
- LEXX 77.63
- GENK 12.50
- 52 Week Low
- LEXX $1.36
- GENK $5.61
- 52 Week High
- LEXX $6.85
- GENK $14.46
- Technical
- Relative Strength Index (RSI)
- LEXX 40.43
- GENK 34.31
- Support Level
- LEXX $1.87
- GENK $7.11
- Resistance Level
- LEXX $2.04
- GENK $7.54
- Average True Range (ATR)
- LEXX 0.22
- GENK 0.33
- MACD
- LEXX -0.02
- GENK -0.02
- Stochastic Oscillator
- LEXX 40.74
- GENK 4.39
About LEXX Lexaria Bioscience Corp.
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.
About GENK GEN Restaurant Group Inc.
GEN Restaurant Group Inc is an Asian casual dining restaurant in the United States. It offers an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables.